# Ashvattha Therapeutics, Inc.: Pharmaceuticals, Redwood City, United States

> Ashvattha Therapeutics, Inc.: Ashvattha Therapeutics, Inc. Based in Redwood City, United States. Founded 2015.

Source: https://millionrounds.com/startup/ashvattha-therapeutics-inc (Millionrounds; every figure on the page links to its filing or article)

United States · [Pharmaceuticals startup](https://millionrounds.com/companies)

# Ashvattha Therapeutics, Inc.

Ashvattha Therapeutics, Inc.

Funding reported Last round: Series B

Pharmaceuticals Redwood City, United States

Company summary

- **Founded:** 2015 11 years old
- **Team:** 22 11 to 50 people
- **Funding reported:** $98M in dollars
- **Last round:** Series B Apr 2023

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Ashvattha Therapeutics, Inc. has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Ashvattha Therapeutics, Inc.

Ashvattha Therapeutics, Inc.

is a clinical-stage biopharmaceutical company based in Redwood City, California. Founded in 2015, the company focuses on developing precision nanomedicines to address unmet medical needs in neurology, ophthalmology, hyperinflammatory diseases, and neuro-oncology. Ashvattha is recognized for its innovative platform that selectively targets and reprograms activated immune cells, such as macrophages and microglia, which play a role in various pathologies. The company's proprietary Hydroxyl Dendrimer (HD) platform enables the creation of Hydroxyl Dendrimer Therapeutics (HDTs) that can cross biological barriers and engage diseased tissues effectively. Ashvattha's product pipeline includes therapeutic candidates like OP-101 for inflammatory diseases, D-4517.2 for ophthalmological conditions, and OP-801, a diagnostic imaging agent for neuro-oncology. The company aims to improve treatment precision and reduce side effects for patients suffering from conditions like age-related macular degeneration, neurological disorders, and severe hyperinflammation.

## What company datasets say Ashvattha Therapeutics, Inc. raised

Funding, as reported

Reported in all **$98M** in dollars

Rounds **4**

Last round **Series B**

Last round size **$50M**

Last round date **Apr 2023**

Investors listed **17**

## Founders and team

From Ashvattha Therapeutics, Inc.'s own website and the SEC filings it signed: 2 on the team.

- **Elizabeth Jeffords** President & CEO of Iolyx Therapeutics
- **Jeffrey Cleland** Executive Officer, Director i

On the board, as filed i *Yuhang Zhao*

## The company, in detail

What they build

Known for

health care inflammatory diseases selective uptake hydroxyl dendrimer drug delivery migaldendranib clinical-stage biopharmaceutical subcutaneous administration neuroinflammation imaging pet tracers for microglia hospital & health care medical inflammation targeting ophthalmology neurology health biotechnology

Built with from their website

Google Maps Google Tag Manager CAPTCHA Google Font API WordPress.org imagesLoaded Microsoft Exchange Nginx Microsoft 365 Font Awesome

+8 more

Onsen UI GeneratePress Intel Nios MySQL Elementor PrimeNG Outlook Django

- **Sector:** Pharmaceuticals
- **Industry code:** NAICS 541714, SIC 2834
- **Region:** California
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/ashvattha-therapeutics)

## Pharmaceuticals in United States

Startups like it

- [**ElevateBio** Waltham · founded 2017 *Raised*](https://millionrounds.com/company/elevatebio)
- [**SpectronRx** Indianapolis · founded 2004 *Raised*](https://millionrounds.com/company/spectronrx)
- [**Epirium Bio** San Diego · founded 2008 *Raised*](https://millionrounds.com/company/epirium-bio)
- [**Sollis** GRANDVIEW · founded 2017 *Raised*](https://millionrounds.com/company/sollis)
- [**Castle Creek Pharmaceuticals** Bernards · founded 2015 *Raised*](https://millionrounds.com/company/castle-creek-pharmaceuticals)
- [**Bryn Pharma** Raleigh · founded 2016 *Raised*](https://millionrounds.com/company/bryn-pharma)
- [**AeroSafe Global** Rochester · founded 1995 *Raised*](https://millionrounds.com/company/aerosafe-global)
- [**AZTherapies** Boston · founded 2011 *Raised*](https://millionrounds.com/company/aztherapies)

## Is this your company?

Add your raise, your deck and your story, and put Ashvattha Therapeutics, Inc. in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)